Original Research
Published on 14 Sep 2022
FAIM2 is a potential pan-cancer biomarker for prognosis and immune infiltration
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.998336
- 5,624 views
- 6 citations


